Puma Biotechnology Closes $138 Million Public Offering of Common Stock

[Business Wire] – Puma Biotechnology, Inc. , a development stage biopharmaceutical company, announced the closing of an underwritten public offering of 1,126,530 shares of its common stock at a price to the public of $122.50 per share. more

View todays social media effects on PBYI

View the latest stocks trending across Twitter. Click to view dashboard

See who Puma is hiring next, click here to view